Description

Multi-targeted therapeutics to treat complex diseasesWe are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principal of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways. We are building a computational-experimental platform to design therapeutics that can target several disease-causing proteins at once. By designing multi-specific drugs, we are able to create therapeutics that are more efficacious and safer than existing medicines.

 


ACTIVE FOUNDERS

Founder 1

Jason Lee,

Working on drug discovery

Twitter: | Linkedin: http://www.linkedin.com/in/jason-l-14043522


Founder 2

Marcel Patek,

I am a chemist with training in Medicinal, Organic, Computational, and Peptide chemistry. In my 25+ years in the field, I carried out drug discovery projects involving small molecules and peptides. I worked in environments of startup and global large pharma companies where I led teams and departments in all aspects of early drug discovery. I currently focus on merging experience-based knowledge of molecular optimization with ML/AI systems.

Twitter: | Linkedin: https://www.linkedin.com/in/marcelpatek/


Founder 3

Rayees Rahman,

Scientist and startup founder

Twitter: | Linkedin: https://www.linkedin.com/in/rayees-rahman-61896117b/


Founder 4

,

Twitter: | Linkedin:


Founder 5

,

Twitter: | Linkedin:


Founder 6

,

Twitter: | Linkedin:

Based in
Nation
Founded in

2021

Team Size

7

Not Available
Today's work schedule is not available
  • Monday

    By appointment only

  • Tuesday

    N/A

  • Wednesday

    N/A

  • Thursday

    N/A

  • Friday

    N/A

  • Saturday

    N/A

  • Sunday

    N/A

  • 9 December 2022 22:50 local time

Follow us
mood_bad
  • No comments yet.
  • Add a review
      error: Content protected